Comparison between Mason Infratech IPO and Nephro Care IPO.
Mason Infratech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Nephro Care IPO is a SME Bookbuilding proposed to list at NSE SME.
| Mason Infratech IPO | Nephro Care IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Expert Global Consultants Pvt.Ltd. | Corporate Capitalventures Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Globalworth Securities Ltd. | SS Corporate Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mason Infratech IPO is up to ₹28.93 Cr whereas the issue size of the Nephro Care IPO is up to ₹39.18 Cr. The final issue price of Mason Infratech IPO is ₹64.00 per share and of Nephro Care IPO is ₹90.00 per share.
| Mason Infratech IPO | Nephro Care IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹62.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹64.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹64.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 45,20,000 shares | 43,53,600 shares |
| Fresh Issue Size (Amount) | up to ₹28.93 Cr | up to ₹39.18 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 45,20,000 shares | 43,53,600 shares |
| Issue Size Total (Amount) | up to ₹28.93 Cr | up to ₹39.18 Cr |
Mason Infratech IPO opens on Jun 24, 2024, while Nephro Care IPO opens on Jun 28, 2024. The closing date of Mason Infratech IPO and Nephro Care IPO is Jun 26, 2024, and Jul 02, 2024, respectively.
| Mason Infratech IPO | Nephro Care IPO | |
|---|---|---|
| Anchor Bid Date | Jun 21, 2024 | Jun 27, 2024 |
| Issue Open | Jun 24, 2024 | Jun 28, 2024 |
| Issue Close | Jun 26, 2024 | Jul 02, 2024 |
| Basis Of Allotment (Tentative) | Jun 27, 2024 | Jul 03, 2024 |
| Initiation of Refunds (Tentative) | Jun 28, 2024 | Jul 04, 2024 |
| Credit of Share (Tentative) | Jun 28, 2024 | Jul 04, 2024 |
| Listing date (Tentative) | Jul 01, 2024 | Jul 05, 2024 |
| Anchor Lockin End date 1 | Jul 27, 2024 | Aug 02, 2024 |
| Anchor Lockin End date 2 | Sep 25, 2024 | Oct 01, 2024 |
Mason Infratech IPO P/E ratio is 24.33, as compared to Nephro Care IPO P/E ratio of 55.15.
| Mason Infratech IPO | Nephro Care IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Mason Infratech Limited Financial Information (Restated)Mason Infratech Limited's revenue increased by 112.76% and profit after tax (PAT) rose by 121.56% between the financial year ending with March 31, 2023 and March 31, 2022.
| Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.20 | 85.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.60 | 61.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 24.33 | 55.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.46 Cr. | ₹148.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.47% | 41.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 30.98% | 36.56% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.63 | ₹1.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 43.47% | 24.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mason Infratech IPO Retail Individual Investors (RII) are offered 15,84,000 shares while in Nephro Care IPO retail investors are offered 15,84,000 shares. Qualified Institutional Buyers (QIB) are offered 9,04,000 shares in Mason Infratech IPO and 8,25,600 shares in Nephro Care IPO.
| Mason Infratech IPO | Nephro Care IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,52,000 shares | 12,38,400 shares |
| Market Maker Reserveration | 2,40,000 shares | 2,30,400 shares |
| QIB | 9,04,000 shares | 8,25,600 shares |
| NII | 6,80,000 shares | 6,19,200 shares |
| RII | 15,84,000 shares | 14,44,800 shares |
| Employee | 2,25,600 shares | |
| Others | ||
| Total | 45,20,000 shares | 43,53,600 shares |
Mason Infratech IPO subscribed 32.89x in total, whereas Nephro Care IPO subscribed 715.78x.
| Mason Infratech IPO | Nephro Care IPO | |
|---|---|---|
| QIB (times) | 13.40x | 245.14x |
| NII (times) | 50.20x | 1,787.19x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 36.59x | 634.12x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 32.89x | 715.78x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
